Literature DB >> 11294671

Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection.

G Fritsche1, C Larcher, H Schennach, G Weiss.   

Abstract

Iron chelation therapy of Plasmodium falciparum infection alleviates the clinical course of cerebral malaria in children. This study assessed the underlying mechanisms of this therapy. Cytokine stimulation of human (intestinal cell line DLD-1) or murine cells (murine macrophage cell line RAW 264.7) resulted in increased nitric oxide (NO) formation and decreased survival of plasmodia within cocultured human erythrocytes. The addition of desferrioxamine (DFO) before cytokine treatment increased both NO formation and parasite killing but had no effect in the presence of the inhibitor of NO formation, L-N6-(1-iminoethyl)-lysine. Moreover, peroxynitrite, which is formed after chemical reaction of NO with superoxide, appears to be the principal effector molecule for macrophage-mediated cytotoxicity toward P. falciparum, and interferon-gamma is a major regulatory cytokine for this process. The effect of DFO on the clearance of plasmodia appears to be due to enhanced generation of NO, rather than to limitation of iron availability to the parasite.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294671     DOI: 10.1086/319860

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Plasmodium berghei resists killing by reactive oxygen species.

Authors:  Peter Sobolewski; Irene Gramaglia; John A Frangos; Marcos Intaglietta; Henri van der Heyde
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species.

Authors:  Long Cui; Jun Miao; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Interaction of Plasmodium falciparum histidine-rich protein II with human lymphocytes leads to suppression of proliferation, IFN-gamma release, and CD69 expression.

Authors:  Padmalaya Das; Jasvir S Grewal; Virander S Chauhan
Journal:  Parasitol Res       Date:  2006-06-21       Impact factor: 2.289

4.  The labile iron pool attenuates peroxynitrite-dependent damage and can no longer be considered solely a pro-oxidative cellular iron source.

Authors:  Fernando Cruvinel Damasceno; André Luis Condeles; Angélica Kodama Bueno Lopes; Rômulo Rodrigues Facci; Edlaine Linares; Daniela Ramos Truzzi; Ohara Augusto; José Carlos Toledo
Journal:  J Biol Chem       Date:  2018-04-16       Impact factor: 5.157

Review 5.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 6.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

7.  Effect of nutrient deficiencies on in vitro Th1 and Th2 cytokine response of peripheral blood mononuclear cells to Plasmodium falciparum infection.

Authors:  Erasto V Mbugi; Marjolein Meijerink; Jacobien Veenemans; Prescilla V Jeurink; Matthew McCall; Raimos M Olomi; John F Shao; Jaffu O Chilongola; Hans Verhoef; Huub F J Savelkoul
Journal:  Malar J       Date:  2010-06-14       Impact factor: 2.979

8.  The iron link between malaria and invasive non-typhoid Salmonella infections.

Authors:  Susanne van Santen; Quirijn de Mast; Dorine W Swinkels; André J A M van der Ven
Journal:  Trends Parasitol       Date:  2013-04-16

9.  Resistance of macrophages to Mycobacterium avium is induced by alpha2-adrenergic stimulation.

Authors:  Kelly E Weatherby; Bruce S Zwilling; William P Lafuse
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.